Schizoaffective Disorders Completed Phase 1 Trials for Paliperidone (DB01267)

Also known as: Schizoaffective disorder / Schizophrenia schizoaffective / Schizoaffective psychosis / Schizo-affective type schizophrenia

IndicationStatusPhase
DBCOND0033299 (Schizoaffective Disorders)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00791622A Study of QT and QTc Intervals in Patients Administered Extended Release Paliperidone or QuetiapineTreatment
NCT00796185As Study of the Pharmacokinetics of Paliperidone Extended-release and Risperidone Immediate-release FormulationsTreatment